CARDIOVASCULAR
hamburger
product photo
THIS DEVICE IS COMMERCIALLY AVAILABLE FOR USE IN SELECT INTERNATIONAL MARKETS.

CAPTURING THE RHYTHM OF LIFE

The Confirm Rx™ insertable cardiac monitor (ICM) with SharpSense™ technology delivers the necessary information you need to clearly and confidently diagnose difficult to detect arrhythmias, including syncope, palpitations and AF before or after ablation therapy and cryptogenic stroke—with fewer interruptions to patients’ daily lives.

The Confirm Rx™ ICM with SharpSense technology and the myMerlin™ mobile app engages patients with easy-to-use tools and enables remote monitoring compliance.

The Confirm Rx ICM with SharpSense technology combines a quick and minimally invasive procedure with Bluetooth® wireless technology, allowing patients to connect using their own mobile devices.

Screencap for the Confirm Rx ICM with the MyMerlin Overview Video

Watch a brief overview of the Confirm Rx™ ICM.

DELIVER CONVENIENTLY
Remote monitoring has never been so engaging.

Remote monitoring via smartphone connectivity with an easy-to-use app encourages patient compliance with less disruption to their daily lives.

  • 97% of registered myMerlin for Confirm Rx mobile app users transmitted at least once.1
  • 1.6 days is the average time between transmissions.1
  • Data is proactively transmitted by the myMerlin for Confirm Rx mobile app per a schedule set by your clinic.
  • The app automatically informs patients of successful device checks and clinic-scheduled transmissions or notifies them when one has been missed.
  • Patients can send patient-triggered symptoms to the clinic without the need to wait for a nightly sync with a traditional transmitter.
DETECT ACCURATELY
Confirm Rx ICM with SharpSense technology significantly improves Bradycardia, Pause and Atrial Fibrillation (AF) detection, ensuring you see what you need to know about your patients.

SharpSense technology is designed with a higher number of discriminators proven to significantly reduce the overall occurrence of a false detection of Bradycardia, Pause and AF,2 while maintaining high relative sensitivity, to give you actionable information you can use to confidently diagnose. In addition, there are print scatterplots to better identify trends for your patients.

An increase in discriminators has led to a 97% reduction in false detection of events.3,*

 

RHYTHM RELATIVE
SENSITIVITY
BRADYCARDIA 98.6%2
PAUSE 98.1%2
AF 97.2%2

Screencap of Jean's ConfirmRx ICM patient story.
Jean's Story: an Animated Patient Experience

Jean is one of the many patients who now use Bluetooth® technology and Confirm Rx™ ICM to monitor his condition. This short animation tells his patient story.

BUILDING COMPREHENSIVE CARDIAC ARRHYTHMIA MANAGEMENT

The Confirm Rx™ ICM with SharpSense™ technology is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-saving technologies that improve therapy outcomes. Read more about the portfolio and our approach to cardiac arrhythmia management.

RESOURCES AND DOCUMENTATION

Product Manuals (Instructions for Use)

REFERENCES

* Determined by evaluation of real-world episodes in previously identified devices, using SharpSense technology.
1. Priorkowski C, et al. Early real-world adoption of mobile remote monitoring using the Confirm Rx Insertable Cardiac Monitor. Poster presented at APHRS. 2018.
2. Design Validation Report and Trace Matrix, Insertable Cardiac Monitor (ICM) System DOC 60076435 Rev. E March 2019.
3. Evaluation of Clinic Impact of Confirm Rx 1.2 Algorithm Enhancements. Abbott document 60098828. April 2019.

THE ADVANTAGES OF CONFIRM Rx™ ICM WITH SHARPSENSE™ TECHNOLOGY

EFFECTIVELY MANAGE PATIENT WITH A QUICK AND MINIMALLY INVASIVE PROCEDURE AND STREAMLINED REMOTE FOLLOW-UP

With the Confirm Rx™ ICM with SharpSense™ technology, you and your patients can benefit from the device's features:

  • SharpSense technology improves the detection of Bradycardia, Pause and Atrial Fibrillation (AF) with high relative sensitivity and significant reduction of false positive episodes1
  • EGM scatterplot reports available as part of episode reports to help streamline data interpretation
  • Small size (~1.4 cc) with slim profile
  • Simple insertion procedure requiring minimal time and resources
  • Programmable data storage options to ensure capture of significant events and reduce the risk that unexpected events are missed
  • MR Conditional: The Confirm Rx™ ICM is conditionally safe for use in the MRI environment when used in accordance to the instructions in the user manual
ENHANCE PATIENT COMPLIANCE TO REMOTE MONITORING

By removing the need for a bedside transmitter and patient activator, Confirm Rx™ ICM with SharpSense™ technology simplifies cardiac monitoring for your patients.

  • 97% of registered myMerlin™ mobile app users transmitted at least once.2
  • 1.6 days is the average time between transmissions.2

 

 

The myMerlin™ for Confirm Rx™ mobile app also:

  • Automatically connects with the device via Bluetooth® low energy wireless technology, and informs patients of successful device checks and clinic-scheduled transmissions, without interrupting their daily lives
  • Alerts patients to connection problems via simple app-based notifications, helping them stay compliant to remote monitoring

 

Download the myMerlin™ for the Confirm Rx™ app today. The app is free and contains a full demo.

apple_iconVisit the Apple‡ App Store to download the myMerlin™ for Confirm Rx™ app

google_play_iconVisit Google Play‡ Store to download the myMerlin™ for Confirm Rx™ app

 

EMPOWER AND ENGAGE PATIENTS

The downloadable myMerlin for Confirm Rx mobile app serves as an integrated transmitter and symptom recorder, as well as a repository of resources for the patient. Help your patients discover greater freedom, increased mobility and better engagement in their own care.

Direct Bluetooth® wireless technology connection to the device and the intuitive design of the myMerlin™ mobile app helps patients stay connected, making it easier for them to transmit data according to the clinic-prescribed schedule.

The myMerlin™ mobile app for Confirm Rx™ ICM with SharpSense™ technology:

  • Offers patients app-based recording of symptomatic events and automatic upload of clinic-scheduled transmissions-all via their own smartphones-with minimal disruptions to their daily lives
  • Allows patients to annotate symptomatic events with specific keywords, such as "fainted" or "fluttering," providing greater clinician insights for confident diagnosis

Patients without a smartphone can receive an Abbott-provided smartphone.

SECURE AND PROTECTED REMOTE MONITORING
  • The Confirm Rx ICM with SharpSense technology uses a proprietary pairing protocol as an added control measure in addition to the pairing procedure specified in Bluetooth® low energy protocols. Pairing requests are authenticated using cloud-based public key cryptography authentication.
  • The Confirm Rx ICM with SharpSense technology creates a unique 128-bit key for the paired mobile app and verifies it at the onset of every communication. If the unique key is not verified, the device denies access.
  • The Confirm Rx ICM with SharpSense technology uses an authorization protocol, which limits a paired mobile app's access based on clinician settings. Encrypted wireless communication uses AES-128 bit encryption and is designed to limit communications to only a single authenticated and paired myMerlin™ mobile app at any given time.
  • The myMerlin mobile app encrypts wireless communication to Merlin.net™ PCN through a secure TLS connection using SHA256 cryptographic protection.
  • Merlin.net PCN is housed in a secured data center and is ISO 27001:2013 certified. Access to patient data in Merlin.net PCN is restricted to authorized users as set by the clinic administrator. Confirm Rx ICM with SharpSense technology data is encrypted using AES-128 bit encryption.
  • Merlin.net PCN is successfully certified through the EU-US Privacy Shield program to transfer patient information from the EU to the US.
BUILDING COMPREHENSIVE CARDIAC ARRHYTHMIA MANAGEMENT

The Confirm Rx™ ICM with SharpSense™ technology is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-saving technologies that improve therapy outcomes. Read more about the portfolio and our approach to cardiac arrhythmia management.

RESOURCES AND DOCUMENTATION

Product Manuals (Instructions for Use)

REFERENCES

1. Design Validation Report and Trace Matrix, Insertable Cardiac Monitor (ICM) System DOC 60076435 Rev E March 2019.
2. Priorkowski C, et al. Early real-world adoption of mobile remote monitoring using the Confirm Rx Insertable Cardiac Monitor. Poster presented at APHRS. 2018.

CONFIRM Rx™

Model DM3500
Insertable Cardiac Monitor

ORDERING INFORMATION

 

Reorder Number

DM3500

Name

Confirm Rx™ ICM

Model Number

DM3500

Description

Insertable cardiac monitor

SEE FULL PRODUCT DETAILS and any references for this product.

 

CUSTOMER
SERVICE

Our customer service experts can help with your
product orders or questions.

: a natural wonder in daylight

OUR PRODUCTS

See our featured innovations and technologies, full product catalog and approach to disease state management.

SJM-CV WEB-0718-0021a(1)

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?